Sign Up to like & get
recommendations!
1
Published in 2022 at "American journal of respiratory and critical care medicine"
DOI: 10.1164/rccm.202112-2824oc
Abstract: RATIONALE Treatment options for idiopathic pulmonary fibrosis (IPF) are limited. OBJECTIVES To evaluate the efficacy and safety of BG00011, an anti-αvβ6 IgG1 monoclonal antibody, in the treatment of patients with IPF. METHODS In a phase…
read more here.
Keywords:
monoclonal antibody;
idiopathic pulmonary;
phase iib;
pulmonary fibrosis ... See more keywords